Around the globe, the composition of society is slowly changing. livers There are more than 1 billion people.
The presence of fat is minimal in the liver of a healthy adult, but many children, and adults as well, have livers with fat levels that exceed this limit. 5 percent or even 10 percent It is about 10% of the total organ weight. The unnatural condition causes inflammation, cellular damage and scarring, which is known as fibrosis. approximately 30 percent of adults worldwide.
Left unchecked, fat accumulation may eventually lead to liver failure. It has also been associated with an increased risk for cardiovascular disease, cancer, and other diseases. It is difficult to diagnose the disease at a young and treatable age because it usually develops with no symptoms. It is possible to have cirrhosis, or scarring in the liver. three-quarters of people Diagnosed only when their conditions becomes life-threatening.
A growing number are looking into how AI can help. Jeffrey Lazarus of the CUNY Graduate School of Public Health and Health Policy suggests AI could be used by a large number of people to comb through electronic health records and find those with the most liver fat.
“AI can retrospectively go through massive numbers of hospital visits and lab reports,” says Lazarus. “You can use that to really prioritize who’s at most risk.”
When fatty liver is detected early, a lot of damage can be reversed. At the beginning, lifestyle modifications such as drinking less alcohol, exercising and eating better, reducing weight, and drinking more coffee can all reverse inflammation and scarring. Novel treatments, such as semaglutide (a GLP-1 drug) and resmetirom (a drug), have shown great promise for those with mild to moderate liver scarring.
“The liver is a very versatile and interesting organ because it can regenerate, fibrosis can be reversed, and you can be completely healthy again,” says Lazarus. “But traditionally, we’ve focused more on late-stage care and trying to see how long we can keep a patient alive rather than finding them early and preventing the condition from advancing.”
Lazarus is frustrated that, despite the existence of simple noninvasive ways to assess liver health, they are not used. Even in those who know their risk for fatty-liver disease (such as people with diabetes type 2) and obesity, which can have serious consequences, the methods are often overlooked.
Fib-4 is one index that rates the risk of advanced liver disease. It does this by calculating a score between 0-6 based upon a person’s age, two levels of liver-enzymes, and blood-clotting capability. The US often includes a liver test in an annual health checkup. The enhanced liver fibrosis blood test is a second-line, more accurate test that doctors can use. It measures two proteins which are involved in scarring and one enzyme which prevents scar tissue from being cleared in the liver.
Use of both tests on patients with liver fat that is concerning has been shown To improve diagnosis by four times for those who have advanced fibrosis. Addition of more tests isn’t a viable option for doctors who face a rising workload.
“You have to have something that can run in the background or it’s easy to just hit a button and do it,” Jonathan Dranoff, professor of Medicine at Yale University.
